BiotechTube
Home/Tempo Therapeutics/Donald Griffin, PhD
DG

Donald Griffin, PhD

Founder & CSO

Tempo Therapeutics

Therapeutic Areas

Surgical OncologySoft Tissue ReconstructionWound Healing

Tempo Therapeutics Pipeline

DrugIndicationPhase
MAP Biosurgery Product (e.g., TT101)Soft tissue reconstruction (Dermal and Abdominal Wall)Pre-clinical

Leadership Team at Tempo Therapeutics

WW
Westbrook Weaver, PhD
Founder & CEO
SD
Stephanie Deshayes, PhD
VP R&D
KU
Kwame Ulmer
Chief Regulatory Officer
TS
Tatiana Segura, PhD
Founder, Scientific Advisor
View full Tempo Therapeutics profile